Discover new approaches to overcoming one of the key bottlenecks in cutaneous gene delivery: achieving efficient, localized nucleic acid delivery without viral vectors or lipid nanoparticles.

Efficient delivery of nucleic acids to skin remains a major challenge for non-viral technologies, limiting their translational potential in vaccines, immunotherapies, and gene-based dermatological applications. In this webinar, Dr. Ria Michalaki, VP of R&D at Piezo Therapeutics, will present preclinical data evaluating an energy-driven, microneedle-based device designed to mechanically enhance delivery of naked nucleic acids to skin. Drawing on results from in vivo animal models and ex vivo skin models, she will demonstrate localized transgene expression and immune activation, while also discussing the current opportunities and limitations of mechanically driven, non-viral delivery strategies.

This session is a must-attend for researchers and developers in gene therapy, vaccines, immunology, dermatology, and drug delivery who are seeking clinically relevant, non-viral approaches for skin-targeted nucleic acid delivery.

Register now to gain insight into the future of mechanically driven gene delivery to skin.